VERMOX 2% Suspension 30ML

Brand Logo
Janssen
Visit store
Get it in 3 hours
Share
Product
Description

VERMOX 2% Suspension 30ML is a broad-spectrum anthelmintic oral suspension containing mebendazole at a 2% concentration (100 mg per 5 mL), designed to treat a wide range of intestinal worm infections in adults and children aged 2 years and older. Manufactured by Janssen (Johnson & Johnson) and available with same-day delivery across the UAE from MEDX Pharmacy, this banana-flavoured liquid formula provides fast, effective relief from threadworms, roundworms, whipworms, and hookworms.


Dosage

1. Threadworms (pinworms): Take one 5 mL dose as a single treatment. A second dose may be needed after 2 to 4 weeks if reinfection occurs.

2. Common worm infections (whipworm, roundworm, hookworm): Take one 5 mL dose twice daily (morning and evening) for 3 consecutive days.

3. Tapeworm infections: Take one 5 mL dose twice daily (morning and evening) for 6 consecutive days.

4. Shake the bottle well before each use and measure with the provided cup.


Important Information

• Not suitable for children under 2 years of age unless specifically prescribed by a doctor

• Do not use during pregnancy - consult your healthcare provider if you are breastfeeding

• Avoid taking mebendazole together with metronidazole due to the risk of serious skin reactions

• Store below 25 degrees Celsius and keep out of reach of children

• This is a prescription medicine - always consult your healthcare provider before use and follow the prescribed dosage


Order VERMOX 2% Suspension 30ML from MEDX Pharmacy for trusted, fast delivery across Dubai and the UAE.

Ingredients

• Mebendazole 2% (20 mg/mL) - a proven anthelmintic from the benzimidazole class

• Effective against threadworms (pinworms), whipworms, roundworms, hookworms, and tapeworms

• Banana-flavoured suspension - easily accepted by both children and adults

• Supplied in a 30 mL bottle with a 5 mL measuring cup for accurate dosing

How to Use

Mebendazole works by blocking the uptake of glucose in parasitic worms, starving them of the energy they need to survive. The active ingredient targets the worms' cellular microtubules, disrupting nutrient absorption until the parasites can no longer sustain themselves. Because the majority of the dose remains in the gastrointestinal tract, mebendazole acts directly where the worms reside, offering targeted treatment with minimal systemic absorption.